AGP Executive Report
Last update: 7 hours agoSwedish Health & Research: A Swedish prospective cohort study links gut microbiome features to future type 2 diabetes risk, hinting at a possible gut-based early warning system. Clinical Trials & AI: A Pistoia Alliance poll says trust and regulatory uncertainty are the biggest barriers to AI adoption in clinical trials, even as regulators signal openness to safer, compliant use. Cancer Care: PALEMA awarded two SEK 25,000 grants to young researchers in oesophageal and gastric cancer, including work on continuous glucose monitoring to reduce “dumping” symptoms after curative oesophageal surgery. Respiratory Health: UK research reports air pollution can slow lung growth in childhood, potentially leaving less “reserve” for later respiratory disease. Public Health Policy: A review finds front-of-pack sugar labels may not meaningfully reduce sugar intake among low-income groups, pointing to limits without broader structural changes. Medication Update: The FDA expanded TREMFYA® (guselkumab) labeling with added support for stopping structural joint damage progression in active psoriatic arthritis. Lifestyle & Weight: A major international analysis suggests obesity rates are leveling off or slowing in some wealthier countries, though the overall burden remains high. Sweden in Focus: Sweden’s new ban on cousin marriages takes effect July 1, 2026, joining a wider global debate on health, genetics, and integration.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.